PSA doubling time was not significantly associated with subsequent adverse biopsy findings and PSA velocity was only marginally significant suggesting that PSA kinetics do not reliably predict disease biology 49 .
← all excerpts
Current approaches, challenges and future directions for monitoring treatment response in prostate cancer.
1
—
—